Wednesday 7 December 2016

INTAS PHARMACEUTICALS LTD WALK IN ON 18/12/16 @ Chitkara University, Pinjore



Dear Candidate, 
Greetings from INTAS!!
WALK-IN INTERVIEW@ HIMACHAL PRADESH
We have opening for Officer / Sr.Officer / Executive in Quality Assurance Department. Please find below details for criteria required for the said position.

Company Profile
Experience spanning three decades in healthcare, with a wide range of formulations to meet the needs of ailing humanity, Intas Pharmaceuticals headquartered at Ahmedabad (India), is now a force to reckon with, in the global pharma horizon. With expertise in a range of formulations, from tablets to injectables to newer drug delivery systems, Intas is currently ranked 17th among the Indian Pharma majors. A variety of initiatives in Research and Development, patents and ANDA filing, NDDS, quality manufacturing support, along with approvals by regulatory authorities of many countries has made Intas a global healthcare provider. Pioneering efforts in providing medications for both chronic and acute medical conditions, has truly led Intas live up to its corporate line �Expressions for a Healthy Life�.
Department – Quality Assurance
Position – Officer / Sr. Officer / Executive
Experience – 2 – 8 Years
Education – B.Sc / M.Sc/ B.Pharma / M.Pharma
Job Location - Ahmedabad (Gujarat)
Venu – Chitkara University, Pinjore – Barotiwala N.H 21A, H.P – 174103.

Date – 18th December,2016 from 9:00 A.M - 6:00 P.M.
Job Description – 
1. Should have experience in IPQA, QMS, Qualification for Solid Oral & Parenteral Manufacturing Plant.
2. Knowledge of SAP will be an added advantage.
3. Exposure of regulatory bodies like USFDA, MHRA, TGA, ANVISA, WHO etc will be added advantage.
Kindly send your updated resume on hrinduction_sez@intaspharma.com; prasenjit_das@intaspharma.com 
Regards,

Meghal Desai 
Executive - Human Resources
Intas Pharmaceuticals Limited
Direct: 02717 – 619938 / 619783
For more updates follow srinivasulutirumalasetty.blogspot.com

Thank you for visiting my blog , Visit again for latest pharma updates

No comments:

Post a Comment